| Common Name | AN100226,AN100226,BG00002 |
|---|---|
| Conjugate | PE-conjugated |
| Synonyms | CD49D;IA4 |
| Applications | Flow Cyt |
| Recommended Dilutions | Flow Cyt 1:100 |
| Formulation & Reconstitution | Liquid PBS with 0.05% Proclin300, 1% BSA |
| Host Species | Humanized |
| IgG type | IgG4 |
| Reactivity | Human |
| Target | |
| Uniprot ID | P13612 |
| Description | PE-conjugated Anti-ITGA4 (natalizumab biosimilar) mAb |
| Delivery | Under Development |
| Storage & Shipping | Store at 2°C-8°C for 6 months |
| Background | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Usage | Research use only |
PE-conjugated Anti-ITGA4 (natalizumab biosimilar) mAb
Price: 100 test $192.00

